{"raw_mentions": "Here are the extracted sentences:\n\nSo, according to compound of the present invention for human body CB\u2081Cannabined receptor has very strong avidity (Ki=5.4nM), and it is compared the avidity (Ki=34nM) of same acceptor with the SR141716 that measures under identical condition and is on a good wicket.\nCompare with N-piperidino-(1-position only)-5-(4-bromophenyl)-1-(2,4 dichloro benzene base)-4-methylpyrazole-3-methane amide (compd A) again according to compound of the present invention.Measure under the same conditions, this compound is to human body CB\u2081The avidity of Cannabined receptor is reflected as the Ki value and is 8nM."}
{"final_json": [{"molecule_name": "compound of the present invention", "protein_target_name": "CB\u2081 Cannabined receptor", "binding_metric": "Ki", "value": "5.4", "unit": "nM"}, {"molecule_name": "SR141716", "protein_target_name": "CB\u2081 Cannabined receptor", "binding_metric": "Ki", "value": "34", "unit": "nM"}, {"molecule_name": "N-piperidino-(1-position only)-5-(4-bromophenyl)-1-(2,4 dichloro benzene base)-4-methylpyrazole-3-methane amide (compd A)", "protein_target_name": "CB\u2081 Cannabined receptor", "binding_metric": "Ki", "value": "8", "unit": "nM"}]}
